๐๐๐
$ABVC BioPharma(ABVC.US$
ABVC BioPharma, Inc.ย (NASDAQ: ABVC) ("Company"), a clinical-stage biopharmaceutical company developing therapeutic solutions in oncology/hematology, CNS, and ophthalmology,
ABVC BioPharma, Inc.ย (NASDAQ: ABVC) ("Company"), a clinical-stage biopharmaceutical company developing therapeutic solutions in oncology/hematology, CNS, and ophthalmology,
Proudly announced today that its CEO, Dr. Uttam Patil,
was selected as one of the Top 10 CEOs in Taiwan 2024 byย CEO Insights Asia Magazine. This recognition is a testament to Dr. Patil's outstanding leadership, innovative vision, and significant contributions to the Company. Dr. Patil is confident in the Company's prospects, so he owns stock options without claiming a salary. Within his first year as the Company's CEO, the Company saw a rise in the stock price of its common stock, an increase in its social media presence, and a renewed focus on its essential products.
as a post-doctoral fellow at National Taiwan Normal after receiving his Ph.D. from the National Tsing Hua University, Department of Chemistry.
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
